{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T21:58:09Z","timestamp":1793570289117,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004826","name":"State of Connecticut Department of Social Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA BC 011115"],"award-info":[{"award-number":["ZIA BC 011115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2 R01 CA120528-12"],"award-info":[{"award-number":["2 R01 CA120528-12"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jtho.2020.08.024","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T09:54:14Z","timestamp":1599818054000},"page":"89-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"16","author":[{"given":"Emily S.","family":"Reardon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichuan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudheer K.","family":"Gara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Straughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden C.","family":"Payabyab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"De Rienzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffit","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Miettinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa T.","family":"Uechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuong D.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Schrump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2020.08.024_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1586\/17476348.2015.1081066","article-title":"Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies","volume":"9","author":"Bononi","year":"2015","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jtho.2020.08.024_bib2","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1073\/pnas.1821510116","article-title":"Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy","volume":"116","author":"Hassan","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jtho.2020.08.024_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/gcc.22670","article-title":"Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes","volume":"57","author":"Betti","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jtho.2020.08.024_bib4","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2020.08.024_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/oemed-2017-104298","article-title":"Estimation of the global burden of mesothelioma deaths from incomplete national mortality data","volume":"74","author":"Odgerel","year":"2017","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.jtho.2020.08.024_bib6","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/ijerph15051000","article-title":"Global asbestos disaster","volume":"15","author":"Furuya","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jtho.2020.08.024_bib7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.21037\/tlcr.2018.04.10","article-title":"Current chemotherapy strategies in malignant pleural mesothelioma","volume":"7","author":"de Gooijer","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtho.2020.08.024_bib8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jtho.2018.08.001","article-title":"Surgery in malignant pleural mesothelioma","volume":"13","author":"Bueno","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2020.08.024_bib9","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jtho.2018.08.2036","article-title":"Current and future management of malignant mesothelioma: a consensus report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation","volume":"13","author":"Tsao","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2020.08.024_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ht7030020","article-title":"Genomics and epigenetics of malignant mesothelioma","volume":"7","author":"Sage","year":"2018","journal-title":"High-Throughput"},{"key":"10.1016\/j.jtho.2020.08.024_bib11","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jtho.2016.05.020","article-title":"The genetic landscape of malignant pleural mesothelioma: results from massively parallel sequencing","volume":"11","author":"Hylebos","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2020.08.024_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.21037\/tlcr.2017.06.06","article-title":"Targeting the epigenome in malignant pleural mesothelioma","volume":"6","author":"McLoughlin","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtho.2020.08.024_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-11-0962","article-title":"Polycomb repressor complex-2 is a novel target for mesothelioma therapy","volume":"18","author":"Kemp","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2020.08.024_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/genes10010065","article-title":"Coordinated dialogue between UHRF1 and DNMT1 to ensure faithful inheritance of methylated DNA patterns","volume":"10","author":"Bronner","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jtho.2020.08.024_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317692205","article-title":"UHRF1: the key regulator of epigenetics and molecular target for cancer therapeutics","volume":"39","author":"Sidhu","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jtho.2020.08.024_bib16","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1038\/ncomms10201","article-title":"A\u00a0cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtho.2020.08.024_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.bjc.6601068","article-title":"ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells","volume":"89","author":"Mousli","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2020.08.024_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ccell.2019.03.003","article-title":"Defining UHRF1 domains that support maintenance of human colon cancer DNA methylation and oncogenic properties","volume":"35","author":"Kong","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2020.08.024_bib19","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1038\/celldisc.2016.7","article-title":"Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer","volume":"2","author":"Jia","year":"2016","journal-title":"Cell Discov"},{"key":"10.1016\/j.jtho.2020.08.024_bib20","doi-asserted-by":"crossref","first-page":"51946","DOI":"10.18632\/oncotarget.17393","article-title":"The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer","volume":"8","author":"Ashraf","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2020.08.024_bib21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13046-016-0453-5","article-title":"Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer","volume":"35","author":"Alhosin","year":"2016","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.jtho.2020.08.024_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/25779","article-title":"DNA hypomethylation leads to elevated mutation rates","volume":"395","author":"Chen","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2020.08.024_bib23","doi-asserted-by":"crossref","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jtho.2020.08.024_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bjc.6605717","article-title":"UHRF1 is a novel diagnostic marker of lung cancer","volume":"103","author":"Unoki","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2020.08.024_bib25","doi-asserted-by":"crossref","first-page":"57821","DOI":"10.18632\/oncotarget.11067","article-title":"UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma","volume":"7","author":"Nakamura","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2020.08.024_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/carcin\/bgz004","article-title":"Prognostic factors of survival in patients with malignant pleural mesothelioma; an analysis of the National Cancer Database","volume":"40","author":"Van Gerwen","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jtho.2020.08.024_bib27","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1016\/j.cllc.2018.08.007","article-title":"Survival by histologic subtype of malignant pleural mesothelioma and the impact of surgical resection on overall survival","volume":"19","author":"Verma","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2020.08.024_bib28","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1074\/jbc.M116.750539","article-title":"The ubiquitin-like with PHD and ring finger domains 1 (UHRF1)\/DNA methyltransferase 1 (DNMT1) axis is a primary regulator of cell senescence","volume":"292","author":"Jung","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtho.2020.08.024_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ydbio.2016.01.036","article-title":"UHRF1 regulation of Dnmt1 is required for pre-gastrula zebrafish development","volume":"412","author":"Kent","year":"2016","journal-title":"Dev Biol"},{"key":"10.1016\/j.jtho.2020.08.024_bib30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/1078-0432.CCR-14-3379","article-title":"Mithramycin depletes specificity protein 1 and activates p53 to mediate senescence and apoptosis of malignant pleural mesothelioma cells","volume":"22","author":"Rao","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2020.08.024_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41598-018-37258-3","article-title":"Activated MEK\/ERK pathway drives widespread and coordinated overexpression of UHRF1 and DNMT1 in cancer cells","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtho.2020.08.024_bib32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm1146","article-title":"Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors","volume":"10","author":"Issaeva","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jtho.2020.08.024_bib33","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1021\/jm400487c","article-title":"Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development","volume":"56","author":"Ding","year":"2013","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jtho.2020.08.024_bib34","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4161\/epi.32088","article-title":"Human factors and pathways essential for mediating epigenetic gene silencing","volume":"9","author":"Poleshko","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.jtho.2020.08.024_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12964-019-0392-9","article-title":"SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways","volume":"17","author":"Yang","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jtho.2020.08.024_bib36","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1158\/0008-5472.CAN-10-0255","article-title":"Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells","volume":"70","author":"Harada","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2020.08.024_bib37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2017.06.105","article-title":"DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer","volume":"490","author":"Huang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtho.2020.08.024_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fonc.2019.00262","article-title":"High expression of DEPDC1 promotes malignant phenotypes of breast cancer cells and predicts poor prognosis in patients with breast cancer","volume":"9","author":"Zhao","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtho.2020.08.024_bib39","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.bcp.2013.10.002","article-title":"Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis","volume":"86","author":"Bronner","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jtho.2020.08.024_bib40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/OTT.S192234","article-title":"Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies","volume":"12","author":"Xue","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jtho.2020.08.024_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007042","article-title":"Role of UHRF1 in de novo DNA methylation in oocytes and maintenance methylation in preimplantation embryos","volume":"13","author":"Maenohara","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jtho.2020.08.024_bib42","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.molcel.2016.04.025","article-title":"Impairment of DNA methylation maintenance is the main cause of global demethylation in naive embryonic stem cells","volume":"62","author":"von Meyenn","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.jtho.2020.08.024_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ccr.2014.01.003","article-title":"UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma","volume":"25","author":"Mudbhary","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2020.08.024_bib44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1101\/gr.208108.116","article-title":"Critical threshold levels of DNA methyltransferase 1 are required to maintain DNA methylation across the genome in human cancer cells","volume":"27","author":"Cai","year":"2017","journal-title":"Genome Res"},{"key":"10.1016\/j.jtho.2020.08.024_bib45","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.1073\/pnas.1612967114","article-title":"Uhrf1 controls the self-renewal versus differentiation of hematopoietic stem cells by epigenetically regulating the cell-division modes","volume":"114","author":"Zhao","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jtho.2020.08.024_bib46","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00280-011-1801-y","article-title":"Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in\u00a0vitro and in\u00a0vivo","volume":"69","author":"Fang","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jtho.2020.08.024_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/09553002.2011.530335","article-title":"UHRF1 confers radioresistance to human breast cancer cells","volume":"87","author":"Li","year":"2011","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.jtho.2020.08.024_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13148-019-0668-3","article-title":"UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells","volume":"11","author":"Niinuma","year":"2019","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jtho.2020.08.024_bib49","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/acs.jproteome.8b00745","article-title":"Proteomic analysis of azacitidine-induced degradation profiles identifies multiple chromatin and epigenetic regulators including Uhrf1 and Dnmt1 as sensitive to azacitidine","volume":"18","author":"Bowler","year":"2019","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.jtho.2020.08.024_bib50","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4161\/cc.27546","article-title":"Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma","volume":"13","author":"Di Marzo","year":"2014","journal-title":"Cell Cycle"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086420307164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086420307164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:44:09Z","timestamp":1761561849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086420307164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1556086420307164"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2020.08.024","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2020.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}